0000728079-16-000003.txt : 20160106 0000728079-16-000003.hdr.sgml : 20160106 20160106124840 ACCESSION NUMBER: 0000728079-16-000003 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20160106 DATE AS OF CHANGE: 20160106 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: PHIBRO ANIMAL HEALTH CORP CENTRAL INDEX KEY: 0001069899 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 131840497 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-88114 FILM NUMBER: 161326056 BUSINESS ADDRESS: STREET 1: GLENPOINTE CENTRE EAST, 3RD FLOOR STREET 2: 300 FRANK W. BURR BLVD., SUITE 21 CITY: TEANECK STATE: NJ ZIP: 07666 BUSINESS PHONE: 201-329-7300 MAIL ADDRESS: STREET 1: GLENPOINTE CENTRE EAST, 3RD FLOOR STREET 2: 300 FRANK W. BURR BLVD., SUITE 21 CITY: TEANECK STATE: NJ ZIP: 07666 FORMER COMPANY: FORMER CONFORMED NAME: PHILIPP BROTHERS CHEMICALS INC DATE OF NAME CHANGE: 19980908 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: FORESTERS INVESTMENT MANAGEMENT COMPANY, INC. CENTRAL INDEX KEY: 0000728079 IRS NUMBER: 136120357 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 40 WALL STREET STREET 2: 10TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10005-1343 BUSINESS PHONE: 212-858-8000 MAIL ADDRESS: STREET 1: 40 WALL STREET STREET 2: 10TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10005-1343 FORMER COMPANY: FORMER CONFORMED NAME: FIRST INVESTORS MANAGEMENT CO INC DATE OF NAME CHANGE: 19960206 SC 13G 1 13gphibroanimalhealth.txt PHIBRO ANIMAL HEALTH CORP. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 __________________________________________________ SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO. __) Phibro Animal Health Corporation ___________________________________________________ (Name of Issuer) Common Stock ___________________________________________________ (Title of Class of Securities) 71742Q106 ___________________________________________________ (CUSIP Number) December 31, 2015 ___________________________________________________ (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: |X| Rule 13d-1(b) |_| Rule 13d-1(c) |_| Rule 13d-1(d) CUSIP No. 71742Q106 1 Name of Reporting Persons Foresters Investment Management Company, Inc. 2 Check the Appropriate Box if a Member of a Group (a) (b) 3 SEC Use Only 4 Citizen Or Place Of Organization Foresters Investment Management Company, Inc. 40 Wall Street - 10th Floor New York, New York 10005 Number of 5 Sole Voting Power Shares 971,395 Beneficially 6 Shared Voting Power Owned By 0 Each 7 Sole Dispositive Power Reporting 971,395 Person With: 8 Shared Dispositive Power 0 9 Aggregate Amount Beneficially Owned By Each Reporting Person 971,395 10 Check If The Aggregate Amount In Row (9) Excludes Certain Shares N/A 11 Percent Of Class Represented By Amount In Row 9 5.4% 12 Type Of Reporting Person IV Item 1. (a) Name of Issuer: Phibro Animal Health Corporation (b) Address of Issuer's Principal Executive Offices: Phibro Animal Health Corporation Glenpointe Center East, 3rd Floor 300 Frank W. Burr Blvd., Ste. 21 Teaneck, NJ 07666-6712 Item 2. (a) Name of Person Filing Foresters Investment Management Company, Inc. (b) Address of Principal Business Office, or, if none, Residence Foresters Investment Management Company, Inc. 40 Wall Street - 10th Floor New York, New York 10005 (c) Citizenship United States (d) Title of Class of Securities Common Stock (e) CUSIP Number 71742Q106 Item 3. If this statement is filed pursuant to Sections 240.13d-1(b) or (c), check whether the person filing is: (a) |_| Broker or dealer registered under section 15 of the Act (14 U.S.C. 78o). (b) |_| Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c). (c) |_| Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c). (d) |X| Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8). (e) |_| An investment adviser in accordance with Section 40.13d-1(b)(1)(ii)(E); (f) |_| An employee benefit plan or endowment fund in accordance with Section 240.13d-1(b)(1)(ii)(F); (g) |_| A parent holding company or control person in accordance with Section 240.13d-1(b)(1)(ii)(G); (h) |_| A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) |_| A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); (j) |_| Group, in accordance with Section 240.13d-1(b)(1)(ii)(J); Item 4. Ownership Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. (a) Amount beneficially owned: 971,395 (b) Percent of class: 5.4% (c) Number of shares as to which the person has: i. Sole power to vote or to direct the vote: 971,395 ii. Shared power to vote or to direct the vote: 0 iii. Sole power to dispose or to direct the disposition of: 971,395 iv. Shared power to dispose or to direct the disposition of: 0 Item 5. Ownership of Five Percent or Less of a Class If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percont of the class of securities, check the following [ ]. Item 6. Ownership of More than Five Percent on Behalf of Another Person N/A Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company N/A Item 8. Identification and Classification of Members of the Group N/A Item 9. Notice of Dissolution of Group N/A Item 10. Certification By signing below, I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. January 6, 2016 ______________________ Date /S/ MARC S. MILGRAM ________________________ Signature Marc S. Milgram Chief Compliance Officer ________________________ Name/Title